{"id":"NCT01783886","sponsor":"Bayer","briefTitle":"Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement","officialTitle":"A Randomized, Double Masked, Active Controlled, Phase III Study of the Efficacy and Safety of Repeated Doses of Intravitreal VEGF Trap Eye in Subjects With Diabetic Macular Edema","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-02","primaryCompletion":"2015-03","completion":"2015-03","firstPosted":"2013-02-05","resultsPosted":"2016-04-05","lastUpdate":"2016-05-12"},"enrollment":381,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Macular Edema"],"interventions":[{"type":"BIOLOGICAL","name":"Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)","otherNames":[]},{"type":"BIOLOGICAL","name":"Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)","otherNames":[]},{"type":"PROCEDURE","name":"Macular Laser Photocoagulation","otherNames":[]}],"arms":[{"label":"Intravitreal Aflibercept Injection 2Q4","type":"EXPERIMENTAL"},{"label":"Intravitreal Aflibercept Injection 2Q8","type":"EXPERIMENTAL"},{"label":"Macular Laser Photocoagulation","type":"ACTIVE_COMPARATOR"}],"summary":"To determine the efficacy of intravitreally (IVT) administered VEGF Trap-Eye on the best-corrected visual acuity (BCVA) assessed by the early treatment diabetic retinopathy study (ETDRS) chart in subjects with diabetic macular edema (DME) with central involvement.","primaryOutcome":{"measure":"Change From Baseline in Best Corrected Visual Acuity (BCVA) as Measured by Early Treatment Diabetic Retinopathy Study (ETDRS) Letter Score at Week 52 - Last Observation Carried Forward (LOCF)","timeFrame":"Baseline up to week 52","effectByArm":[{"arm":"Intravitreal Aflibercept Injection 2Q4","deltaMin":13.7,"sd":8.4},{"arm":"Intravitreal Aflibercept Injection 2Q8","deltaMin":12.8,"sd":9.5},{"arm":"Macular Laser Photocoagulation","deltaMin":-0.2,"sd":13.5}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG001 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":7},"locations":{"siteCount":25,"countries":["China","Hong Kong","Russia","South Korea"]},"refs":{"pmids":["32210527","31904267"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":19,"n":127},"commonTop":["Visual acuity reduced","Diabetic retinal oedema","Retinal haemorrhage","Conjunctival haemorrhage","Diabetes mellitus"]}}